This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
BA.4/BA.5 early surge report Austria (preprint)
medrxiv; 2022.
Preprint
in English
| medRxiv | ID: ppzbmed-10.1101.2022.07.12.22277534
ABSTRACT
More than two years into the COVID-19 pandemic, the emergence of the Omicron subvariants BA.4 and BA.5 initiated the fifth wave. BA.4/BA.5 share identical spike proteins and are thus difficult to differentiate using standard diagnostic tests. The true frequency and diversity of the two variants in Austria is therefore largely unknown. Aim of this report is to take stock about the frequency and diversity of BA.4 & BA.5 and their subvariants based on whole genome sequencing (WGS) data as deposited at GISAID database. Results show that most sequenced cases belong to BA.5 (c. 86 %) rather than BA.4 (c. 14 %) and that most of the global diversity (24 out of 32 subvariants) of BA.4 and BA.5 in terms of subvariants described is already present in Austria. However, most cases can be attributed to a few subvariants (e.g. BA.5.1, BE.1.1, BA.5.3, BA.5.2.1) with high estimated growth advantage over BA.2 (ranging 103 to 159 %) and may be worth monitoring as the immediate wave unfolds.
Full text:
Available
Collection:
Preprints
Database:
medRxiv
Main subject:
Genomic Instability
/
COVID-19
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS